Conference Commentary: Extracorporeal Membrane Oxygenation (ECMO) for Severe Acute Respiratory Distress Syndrome (ARDS) and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial

Alain Mercat, MD, of the University of Angers, France, comments on the findings of a post hoc Bayesian Analysis of the EOLIA trial, which compared the effects on mortality of venovenous extracorporeal membrane oxygenation (ECMO) vs conventional mechanical ventilation on outcomes for patients with severe acute respiratory distress syndrome (ARDS). Comments were made at the European Society for Intensive Care Medicine (ESICM) 31st Annual Congress, LIVES 2018, on October 22 in Paris. Used with permission.